Literature DB >> 20207980

Effects of bone marrow mesenchymal stem cell transplantation on light-damaged retina.

Yu Zhang1, Wei Wang.   

Abstract

PURPOSE. To investigate the effects and possible mechanisms of rat bone marrow mesenchymal stem cell (BMSC) transplantation on the light-damaged retinal structure and the apoptosis of photoreceptors. METHODS. DAPI-labeled BMSCs were transplanted into the subretinal space of light-damaged Sprague-Dawley rats 10 days after exposure. BMSCs were cultivated with the supernatant of homogenized retina (SHR). RESULTS. The outer nuclear layer (ONL) contained significantly more cells and the percentage of apoptotic ONL cells was significantly reduced in the BMSC transplantation group than in the phosphate-buffered solution injection group or the light damage group. Most DAPI-labeled BMSCs expressed brain-derived neurotrophic factor (BDNF). There was elevated basic fibroblast growth factor (bFGF) and BDNF immunoreactivity in the retinas of the BMSC transplantation group compared with the light damage group. In vitro culture showed that 10% of BMSCs changed from fusiform shape to multipolar shape. A fraction of cells expressed MAP2 or glial fibrillary acidic protein, and some cells expressed bFGF or BDNF when cultivated with light-damaged SHR for 7 days. CONCLUSIONS. BMSC subretinal transplantation could inhibit photoreceptor apoptosis and slow down retinal damage in light-damaged eyes. BMSCs could express bFGF (in vitro) and BDNF (in vitro and in vivo), pointing to potential trophic and protective effects on light-damaged retinas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207980     DOI: 10.1167/iovs.08-3314

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

Review 1.  Stem cells for retinal replacement therapy.

Authors:  Jeffrey H Stern; Sally Temple
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 2.  Mobilizing endogenous stem cells for retinal repair.

Authors:  Honghua Yu; Thi Hong Khanh Vu; Kin-Sang Cho; Chenying Guo; Dong Feng Chen
Journal:  Transl Res       Date:  2013-11-22       Impact factor: 7.012

Review 3.  Stem cell therapy for retinal diseases: update.

Authors:  Rubens Camargo Siqueira
Journal:  Stem Cell Res Ther       Date:  2011-12-29       Impact factor: 6.832

Review 4.  The emerging role of stem cells in ocular neurodegeneration: hype or hope?

Authors:  Neeru Jindal; Asok Mukhopadhyay; Akshay Anand
Journal:  Mol Cell Biochem       Date:  2012-06       Impact factor: 3.396

Review 5.  Stem cell therapies in the management of diabetic retinopathy.

Authors:  Roly Megaw; Bal Dhillon
Journal:  Curr Diab Rep       Date:  2014-07       Impact factor: 4.810

6.  Mesenchymal stem cells for retinal diseases.

Authors:  Wei Xu; Guo-Xing Xu
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

Review 7.  Stem cell-based therapies for age-related macular degeneration: current status and prospects.

Authors:  Yalin Mu; Manli Zhao; Guangming Su
Journal:  Int J Clin Exp Med       Date:  2014-11-15

8.  Progranulin, a major secreted protein of mouse adipose-derived stem cells, inhibits light-induced retinal degeneration.

Authors:  Kazuhiro Tsuruma; Mika Yamauchi; Sou Sugitani; Tomohiro Otsuka; Yuta Ohno; Yuki Nagahara; Yuka Ikegame; Masamitsu Shimazawa; Shinichi Yoshimura; Toru Iwama; Hideaki Hara
Journal:  Stem Cells Transl Med       Date:  2013-11-14       Impact factor: 6.940

Review 9.  Stem cell therapies in the treatment of diabetic retinopathy and keratopathy.

Authors:  Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-09

10.  Basic fibroblast growth factor expression is implicated in mesenchymal stem cells response to light-induced retinal injury.

Authors:  Wei Xu; Xiaoting Wang; Guoxing Xu; Jian Guo
Journal:  Cell Mol Neurobiol       Date:  2013-09-13       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.